Literature DB >> 3776819

Ventricular arrhythmias during reperfusion.

F C Miller, M W Krucoff, L F Satler, C E Green, R D Fletcher, A A Del Negro, D L Pearle, K M Kent, C E Rackley.   

Abstract

Accelerated idioventricular rhythm has been used as a marker for coronary reperfusion. The incidence of accelerated idioventricular rhythm and ventricular tachycardia was evaluated in 52 consecutive patients undergoing thrombolysis with intracoronary streptokinase during acute myocardial infarction. Complete 12-hour Holter recordings during and after intracoronary streptokinase were obtained in 39 patients. Reperfusion was documented in 17 patients (44%), no reperfusion in 14 (36%), and subtotal occlusion in eight (20%). Accelerated idioventricular rhythm occurred in 83%, 57%, and 63% of patients by group, respectively (p greater than 0.05). Ventricular tachycardia occurred in 100%, 71%, and 100% of patients by group, respectively (p less than 0.05). These data demonstrate that accelerated idioventricular rhythm is not specific for reperfusion and cannot be used as a marker for this event, and that ventricular tachycardia is more common with reperfusion and subtotal occlusion.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3776819     DOI: 10.1016/0002-8703(86)90302-9

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  5 in total

1.  French multicenter trial of anistreplase versus heparin in acute myocardial infarction.

Authors:  H Lardoux; Y Louvard; D de Vernejoul; C Picot; M Baudet; M Hiltgen; M Houplon; J Ponsonnaille; M Richard; R Luccioni
Journal:  Cardiovasc Drugs Ther       Date:  1990-10       Impact factor: 3.727

2.  Predictive value of ventricular arrhythmias for patency of the infarct-related coronary artery after thrombolytic therapy.

Authors:  A J Six; J H Louwerenburg; J H Kingma; E O Robles de Medina; N M van Hemel
Journal:  Br Heart J       Date:  1991-08

Review 3.  Adverse reactions to thrombolytic agents. Implications for coronary reperfusion following myocardial infarction.

Authors:  J Nazari; R Davison; K Kaplan; D Fintel
Journal:  Med Toxicol Adverse Drug Exp       Date:  1987 Jul-Aug

4.  Ventricular arrhythmias during treatment with alteplase (recombinant tissue plasminogen activator) in suspected acute myocardial infarction.

Authors:  R G Wilcox; J Eastgate; E Harrison; A M Skene
Journal:  Br Heart J       Date:  1991-01

5.  Holter monitoring of ventricular arrhythmias in a randomised, controlled study of intravenous streptokinase in acute myocardial infarction.

Authors:  D Alexopoulos; R Collins; S Adamopoulos; R Peto; P Sleight
Journal:  Br Heart J       Date:  1991-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.